Crizotinib promotes the occurrence of inferior vena cava thrombosis and pulmonary embolism in cold-exposed mice by affecting endothelial cells and macrophages
Preprint
- 12 March 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Despite reports of pulmonary embolism (PE) as a major adverse effect of Crizotinib, the underlying mechanisms remain unclear. This study investigated the pro-thrombotic effects of Crizotinib in mice and its cellular impact. Methods Mice underwent inferior vena cava(IVC )ligation or carrageenan-induced tail thrombosis with Crizotinib treatment. Thrombosis incidence and pathology were assessed. In vitro, Crizotinib's effects on human umbilical vein endothelial cell (HUVEC) survival, apoptosis, and permeability, and macrophage polarization and phagocytosis were evaluated. Results Crizotinib can cause IVC thrombosis in mice undergoing laparotomy sham surgery. In the Balb/c mouse IVC and tail thrombosis model induced with carrageenan injection, Crizotinib demonstrated an inflammation-independent thrombopromoting effect. In vivo studies in different strains of mice at an ambient temperature of 18°C (but not 25°C) confirmed that Crizotinib has the effect of promoting IVC thrombosis and PE. Mechanistically, Crizotinib induced HUVEC apoptosis and decreased their survival, compromising the endothelial barrier. Additionally, Crizotinib inhibited macrophage polarization and phagocytosis. Conclusion Crizotinib significantly increases thrombosis in mice, likely due to its detrimental effects on endothelial barrier integrity and macrophage function, highlighting potential mechanisms for its clinical association with PE.Keywords
All Related Versions
This publication has 31 references indexed in Scilit:
- Low ambient temperature might trigger the symptom onset of pulmonary embolism: A nationwide case-crossover study at hourly level in ChinaScience of The Total Environment, 2022
- The clearance of dead cells by efferocytosisNature Reviews Molecular Cell Biology, 2020
- Cellular and molecular mechanisms of HGF/Met in the cardiovascular systemClinical Science, 2015
- Macrophage plasticity and polarization in tissue repair and remodellingThe Journal of Pathology, 2012
- Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)Journal of Medicinal Chemistry, 2011
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic bloodNature Medicine, 2007
- Virchow's Triad Revisited: The Importance of Soluble Coagulation Factors, the Endothelium, and PlateletsThrombosis Research, 2001
- The Effect of Short-Term Cold Exposure on Risk Factors for Cardiovascular DiseaseThrombosis Research, 1999
- Carrageenin-induced thrombosis in rats and mice: A model for testing antithrombotic substances?Inflammation Research, 1985